Company · TRXB
TRex Bio, Inc.
Nasdaq's symbol directory lists TRXB on Nasdaq as “TRex Bio, Inc. - Common stock”.
In the 12 months to Nov 8, 2026: insiders bought on 2 occasions ($3.8M); 4 filings by holders of 5% or more; 1 company report (Form 8-K, since May 26, 2026).
All insider filings at the SEC · Appeared in No. 29, No. 28, No. 27, No. 26, No. 25, No. 24, No. 23, No. 22
Insider trades · SEC Form 4
Those inside the hall
Open-market purchases and sales only. Legs one person filed for one day are combined.
Who traded
- Alexandria Venture Investments, LLC bought $2.5M
- SVLSF VI, LLC bought $1.3M
Every trade (2)
- BUYAlexandria Venture Investments, LLC bought $2.5M
- BUYSVLSF VI, LLC bought $1.3M
Large holders · SEC Schedules 13D and 13G
Five percent and over
Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G
- ELI LILLY & Co 19.9%
- PFIZER INC. (13-5315170) 7.2%
- SV Biotech Crossover Opportunities Fund LP 7%
- Johnson & Johnson Innovation - JJDC, Inc. 5.3%
Company reports · SEC Form 8-K
In its own words
Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.
- Amendments to articles or bylaws; change in fiscal year Oct 13, 2026
Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.